US80810D1037
© BusinessWire
12.01.2026
SDGR
LISTED
NASDAQ
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its physics+AI computational platform and serving as a global leader in computational molecular discovery.
“In 2025, we witnessed the continued impact of...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
SDGR
LISTED
NASDAQ
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development by providing access to advanced artificial intelligence (AI) capabilities. TuneLab will be made available in LiveDesign, Schrödinger’s widely used enterpris...
Themefolio
Profiler
Peergroup
© BusinessWire
17.12.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on December 15, 2025, the company granted restricted stock units (RSUs) with respect to 2,666 shares of the company’s common stock to 6 newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of th...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
06.11.2025
SDGR
LISTED
NASDAQ
Schrödinger to Present at Jefferies London Healthcare Conference
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 19, at 4:00 p.m. GMT (11:00 a.m. ET).
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be arch...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
05.11.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Third Quarter 2025 Financial Results
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the quarter ended September 30, 2025.
"Schrödinger delivered a solid third quarter with software revenue growth of 28%, reflecting the industry’s increasing demand for our leading computational platform,” said Ramy Farid, Ph.D., chief executive officer of Schrödinger. “While w...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
SDGR
LISTED
NASDAQ
Schrödinger to Announce Third Quarter 2025 Financial Results on November 5
News Preview
Schrödinger (Nasdaq: SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on October 13, 2025, the company granted restricted stock units (RSUs) with respect to 14,888 shares of the company’s common stock to 10 newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of t...
Themefolio
Profiler
Peergroup
© BusinessWire
18.09.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on September 14, 2025, the company granted restricted stock units (RSUs) with respect to 1,666 shares of the company’s common stock to four newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee o...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
SDGR
LISTED
NASDAQ
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The live presentation will take place on Monday, September 8, 2025 at 11:30 a.m. E.T.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be...
Themefolio
Profiler
Peergroup
© BusinessWire
15.08.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 15, 2025, the company granted restricted stock units (RSUs) with respect to 1,875 shares of the company’s common stock to two newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of th...
Themefolio
Profiler
Peergroup
© BusinessWire
14.08.2025
SDGR
LISTED
NASDAQ
Schrödinger Announces Discontinuation of SGR-2921 Program
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced the discontinuation of the clinical development program for SGR-2921, its CDC7 inhibitor, which was being evaluated in a Phase 1 dose-escalation study in patients with relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.
Despite early evidence of monotherapy activity...
Themefolio
Profiler
Peergroup
© BusinessWire
25.07.2025
SDGR
LISTED
NASDAQ
Schrödinger to Announce Second Quarter 2025 Financial Results on August 6
News Preview
Schrödinger (Nasdaq: SDGR) will report its second quarter 2025 financial results on Wednesday, August 6, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
18.07.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on July 14, 2025, the company granted restricted stock units (RSUs) with respect to 3,488 shares of the company’s common stock to three newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of th...
Themefolio
Profiler
Peergroup
© BusinessWire
17.07.2025
SDGR
LISTED
NASDAQ
Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target
News Preview
Ajax Therapeutics, Inc. and Schrödinger, Inc. (Nasdaq: SDGR) today announced an expansion of their exclusive research collaboration to include a new Janus kinase (JAK) target. The partnership was established in 2019 with a goal of leveraging Schrödinger’s advanced computational platform and Ajax’s structural biology insights to develop a pipeline...
Themefolio
Profiler
Peergroup
© BusinessWire
27.06.2025
SDGR
LISTED
NASDAQ
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that SGR-1505, its clinical stage MALT1 inhibitor, was designated as a Fast Track product by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Waldenström macroglobulinemia that have failed at least two lines of therapy, including a Bruton’s tyrosine kinase (BTK) i...
Themefolio
Profiler
Peergroup
© BusinessWire
17.06.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on June 13, 2025, the company granted restricted stock units (RSUs) with respect to 10,290 shares of the company’s common stock to five newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of th...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced encouraging initial clinical data from its ongoing Phase 1, open-label, dose-escalation study of SGR-1505 in patients with relapsed/refractory B-cell malignancies. SGR-1505 was observed to be safe, well tolerated, and clinically active, with responses observed in multiple histologies, including in p...
Themefolio
Profiler
Peergroup
© BusinessWire
29.05.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced the grant of inducement equity awards to the company’s newly appointed EVP, Chief Commercial Officer, Global Head of Software Sales & Marketing, Mannix Aklian. As previously announced, Mr. Aklian joined the company on May 28, 2025. The grants were made pursuant to the company’s 2021 Inducement E...
Themefolio
Profiler
Peergroup
© BusinessWire
29.05.2025
SDGR
LISTED
NASDAQ
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced the expansion of its leadership team with the appointment of Mannix Aklian as executive vice president, chief commercial officer, global head of software sales and marketing. Mr. Aklian brings more than 25 years of experience in software sales and leadership roles within the biopharmaceutical and te...
Themefolio
Profiler
Peergroup
© BusinessWire
23.05.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on May 21, 2025, the company granted restricted stock units (RSUs) with respect to 7,051 shares of the company’s common stock to seven newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the...
Themefolio
Profiler
Peergroup
© BusinessWire
22.05.2025
SDGR
LISTED
NASDAQ
Schrödinger to Present at Jefferies Global Healthcare Conference
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on Wednesday, June 4, 2025 at 1:25 p.m. E.T.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approxi...
Themefolio
Profiler
Peergroup
© BusinessWire
20.05.2025
SDGR
LISTED
NASDAQ
Schrödinger Announces CFO Appointment
News Preview
Schrödinger (Nasdaq: SDGR) today announced that the company and Geoffrey Porges, MBBS., have mutually agreed that Dr. Porges will depart from his role as chief financial officer to pursue other opportunities. Richie Jain, who previously served as Schrödinger’s senior vice president, strategic finance and head of corporate and business development,...
Themefolio
Profiler
Peergroup
© BusinessWire
14.05.2025
SDGR
LISTED
NASDAQ
Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that initial Phase 1 clinical data for SGR-1505, its investigational MALT1 inhibitor, will be presented at the European Hematology Association Annual Congress, taking place June 12 - 15, 2025, in Milan, Italy. Additional data from this trial will be presented at the International Conference on Malig...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Strong First Quarter 2025 Financial Results
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the quarter ended March 31, 2025.
“We are very pleased with Schrödinger’s performance in the first quarter of 2025, with strong software and drug discovery revenue growth. Our proprietary pipeline is progressing, and we are looking forward to reporting initial data from the Ph...
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
SDGR
LISTED
NASDAQ
Schrödinger to Present at BofA Securities 2025 Healthcare Conference
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the BofA Securities 2025 Healthcare Conference. The live presentation will take place on Wednesday, May 14, 2025 at 4:40 p.m. ET.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for appr...
Themefolio
Profiler
Peergroup
© BusinessWire
28.04.2025
SDGR
LISTED
NASDAQ
Schrödinger Presents New Preclinical Data at AACR Annual Meeting
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) presented preclinical data on SGR-3515, its investigational Wee1/Myt1 co-inhibitor today at the American Association for Cancer Research (AACR) Annual Meeting 2025. The data demonstrated that SGR-3515 has improved anti-tumor activity in preclinical models compared to known Wee1 and Myt1 monotherapy inhibitors. The...
Themefolio
Profiler
Peergroup
© BusinessWire
23.04.2025
SDGR
LISTED
NASDAQ
Schrödinger to Announce First Quarter 2025 Financial Results on May 7
News Preview
Schrödinger (Nasdaq: SDGR) will report its first quarter 2025 financial results on Wednesday, May 7, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days follo...
Themefolio
Profiler
Peergroup
© BusinessWire
18.04.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on April 16, 2025, the company granted (i) a non-statutory stock option to purchase 3,300 shares of the company’s common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 12,866 shares of the company’s common stock to six newly hired employees. These grants...
Themefolio
Profiler
Peergroup
© BusinessWire
14.04.2025
SDGR
LISTED
NASDAQ
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or potentially replace current animal testing requirements with new approaches designed to improve drug safety and accelerate the evaluation process, while reducing animal experimentation. The FDA’s roadmap encourages a number of...
Themefolio
Profiler
Peergroup
© BusinessWire
25.03.2025
SDGR
LISTED
NASDAQ
Schrödinger to Present Preclinical Data at AACR Annual Meeting
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, and SGR-4174, its SOS1 inhibitor, will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25 - 30, 2025 in Chicago, IL.
The SGR-3515 presentation will include dat...
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company’s common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 6,943 shares of the company’s common stock to seven newly hired employees. These grant...
Themefolio
Profiler
Peergroup
© BusinessWire
10.03.2025
SDGR
LISTED
NASDAQ
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250310010062/en/Bridget van Kralingen was appointed to Schrödinger’s Board of Directors in March 2...
Themefolio
Profiler
Peergroup
© BusinessWire
26.02.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the fourth quarter and full-year ended December 31, 2024, and provided its financial outlook for 2025.
“We are delighted with Schrödinger’s excellent financial performance in 2024. Software revenue growth exceeded our expectations, showing the resilience of our business throu...
Themefolio
Profiler
Peergroup
© BusinessWire
24.02.2025
SDGR
LISTED
NASDAQ
Schrödinger to Participate in Upcoming Investor Conferences
News Preview
Schrödinger (Nasdaq: SDGR) today announced that management will participate in the following conferences in March:
TD Cowen 45th Annual Health Care Conference: Fireside chat on Tuesday, March 4, 2025 at 10:30 a.m. E.T.
Leerink Partners Global Biopharma Conference 2025: Fireside chat on Monday, March 10, 2025 at 3:40 p.m. E.T.
KBCM Healthcare...
Themefolio
Profiler
Peergroup
© BusinessWire
20.02.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on February 17, 2025, the company granted restricted stock units (RSUs) with respect to 5,445 shares of the company’s common stock to five newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
SDGR
LISTED
NASDAQ
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26
News Preview
Schrödinger (Nasdaq: SDGR) will report its fourth quarter and full-year 2024 financial results on Wednesday, February 26, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for appro...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2025
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on January 20, 2025, the company granted restricted stock units (RSUs) with respect to 4,840 shares of the company’s common stock to four newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
SDGR
LISTED
NASDAQ
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for 2025.
“We are very proud of our accomplishments in 2024. We advanced the capabilities of our computational platform and leveraged the synergies in our business, which included signing a multi-target res...
Themefolio
Profiler
Peergroup
© BusinessWire
17.12.2024
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on December 12, 2024, the company granted restricted stock units (RSUs) with respect to 8,365 shares of the company’s common stock to six newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2024
SDGR
LISTED
NASDAQ
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference. The live presentation will take place on Wednesday, December 4, 2024 at 8:30 a.m. ET.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archive...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2024
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on November 14, 2024, the company granted restricted stock units (RSUs) with respect to 2,785 shares of the company’s common stock to four newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of...
Themefolio
Profiler
Peergroup
© BusinessWire
18.11.2024
SDGR
LISTED
NASDAQ
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative
News Preview
Schrödinger, Inc. (Nasdaq: SDGR), today announced that it is broadening and accelerating its initiative to expand the company’s computational platform to predict toxicology risk early in drug discovery. The goal of the initiative, announced earlier this year, is to develop a computational solution designed to improve the properties of novel drug d...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2024
SDGR
LISTED
NASDAQ
Schrödinger Reports Third Quarter 2024 Financial Results
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the third quarter of 2024 and provided a business update. In a separate press release issued earlier today, Schrödinger announced a multi-target research and licensing collaboration with Novartis. Under the terms of the agreement, Novartis will pay Schrödinger $150 million upfr...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2024
SDGR
LISTED
NASDAQ
Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced a research collaboration and license agreement with Novartis to advance multiple development candidates into Novartis’s portfolio for further development. The companies also announced an expanded three-year software agreement that substantially increases Novartis's access to Schrödinger’s computatio...
Themefolio
Profiler
Peergroup
© BusinessWire
04.11.2024
SDGR
LISTED
NASDAQ
Schrödinger to Present at Jefferies London Healthcare Conference
News Preview
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 20, at 8:30 a.m. GMT (3:30 a.m. ET)...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2024
SDGR
LISTED
NASDAQ
Schrödinger to Announce Third Quarter 2024 Financial Results on November 12
News Preview
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its third quarter 2024 financial results on Tuesday, November 12, 2024, before the financial markets open. The company will host a conference call and webcast at 8:00 a.m. ET.
The live webcast can b...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2024
SDGR
LISTED
NASDAQ
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium
News Preview
Schrödinger (Nasdaq: SDGR) today announced new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, during a poster session at the 36th EORTC-NCI-AACR Symposium (ENA 2024). The data demonstrate that in preclinical models, treatment with SGR-3515 results in synergistic anti-tumor activity that leads to deeper and more durable resp...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2024
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on October 12, 2024, the company granted (i) a non-statutory stock option to purchase 5,700 shares of the company’s common stock to one newly hired employee and (ii) restricted stock un...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2024
SDGR
LISTED
NASDAQ
Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium
News Preview
Schrödinger (Nasdaq: SDGR) today announced that new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, and the company’s PRMT5-MTA inhibitor program, will be presented during poster sessions at the 36th EORTC-NCI-AACR Symposium (ENA 2024) taking place October 23-25, 2024 in Barcelona, Spain.
The SGR-3515 presentation will incl...
Themefolio
Profiler
Peergroup
© BusinessWire
18.09.2024
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on September 13, 2024, the company granted restricted stock units (RSUs) with respect to 7,025 shares of the company’s common stock to eight newly hired employees. These grants were mad...
Themefolio
Profiler
Peergroup
© BusinessWire
16.08.2024
SDGR
LISTED
NASDAQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on August 14, 2024, the company granted restricted stock units (RSUs) with respect to 7,500 shares of the company’s common stock to 13 newly hired employees. These grants were made purs...
Themefolio
Profiler
Peergroup
© BusinessWire
14.08.2024
SDGR
LISTED
NASDAQ
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
News Preview
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference. The live presentation will take place on Wednesday, September 4, 2024, at 3:20...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
